Staples vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Largest US office supplies retailer with ~916 stores. Pivoting to services (printing, shipping, passports) and in-store partnerships with Verizon and Party City.
About
Staples is the largest office supplies retailer in the United States, founded in 1986 in Brighton, Massachusetts. The company pioneered the office superstore format and built its brand on the promise of making office supply purchasing convenient and affordable for businesses and consumers alike. Staples was taken private by Sycamore Partners in 2017 and has since been undergoing a significant strategic transformation away from commodity product retail toward services-led revenue.\n\nStaples operates approximately 916 US retail stores and a large B2B commercial division serving businesses directly. The company's retail stores have evolved into multi-service destinations offering printing, shipping, passport photo services, and in-store partnerships with Verizon and Apple — making stores a hub for business services rather than just product sales. The B2B commercial division, which serves small businesses and enterprise accounts with recurring supply contracts, has become the more strategically important revenue stream as retail foot traffic has declined.\n\nStaples generates substantial revenue across its retail and commercial segments, though the company does not disclose detailed financials as a private entity. Its 2025–2026 strategy focuses on growing the services footprint in stores, expanding the B2B commercial business through direct sales and e-commerce, and differentiating from Amazon Business through the combination of physical presence, service offerings, and category expertise. The pivot to services represents a credible response to the existential challenge that e-commerce has posed to traditional office supply retail.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.